Gawah Holdings Takes Strategic Equity in Digipharm Ltd.
January 13, 2022
Gawah Holdings Inc. has taken a strategic equity stake in Digipharm Ltd. to help implement Digipharm's value-based healthcare platform across the GCC, beginning with the United Arab Emirates. Digipharm provides a value-based contracting platform linking manufacturers, payers and providers and plans to expand its solutions into the MENA region with Gawah's support.
- Buyers
- Gawah Holdings Inc.
- Targets
- Digipharm ltd.
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Gawah Holdings Inc. Takes Strategic Equity in Maskarade LLC
October 25, 2021
Consumer Products
Gawah Holdings Inc., a multi-industry investment holding company focused on the MENA region, has taken a strategic equity stake in Maskarade LLC, a U.S.-based health-fashion mask brand founded by Andraya deCo'rdova (Draya Blanco). The investment is intended to provide growth capital and strategic partnership support as Maskarade expands its health-fashion product line and explores integration of wearable technology.
-
CGE Partners Invests in Datapharm
February 28, 2022
Pharmaceuticals
CGE Partners has made a growth investment in Datapharm, the UK-based provider of regulatory-driven medicines information and software (including the electronic medicines compendium, emc). The investment will partner with Datapharm's management to accelerate new product development, international expansion, and support strategic acquisitions.
-
GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian
November 5, 2020
Healthcare Services
GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.
-
GHO Capital Acquires Majority Stake in Sterling Pharma Solutions
February 28, 2019
Pharmaceuticals
GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.
-
H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals
December 13, 2021
Pharmaceuticals
An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.
-
GHO Capital and Partners Group Invest in Sterling Pharma Solutions
May 25, 2023
Pharmaceuticals
GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.